People with PAD may benefit from nicotinamide riboside to enhance mitochondrial activity and walking performance. The clinical trial showed promising results after 6 months of supplementation.
This study highlights the potential of vitamin B3, specifically nicotinamide riboside, as a possible treatment option for individuals with peripheral artery disease who struggle with walking difficulties.
Collection
[
|
...
]